FivepHusion

FivepHusion is an Australian private biotechnology company that is developing Defleifol™, a new drug formulation aimed at meeting oncologists' demand for safer and more effective chemotherapy. Deflexifol™ combines the chemotherapy drug 5-fluorouracil (5-FU) with its biomodulator leucovorin to enhance the antitumor activity of 5-FU.These drugs are commonly used to treat various solid tumors, including colorectal cancer, pancreatic cancer, and breast cancer.